Aisling Capital Management LP Aclaris Therapeutics, Inc. Transaction History
Aisling Capital Management LP
- $286 Million
- Q1 2025
A detailed history of Aisling Capital Management LP transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Aisling Capital Management LP holds 434,455 shares of ACRS stock, worth $625,615. This represents 0.23% of its overall portfolio holdings.
Number of Shares
434,455
Previous 434,455
-0.0%
Holding current value
$625,615
Previous $1.08 Million
38.35%
% of portfolio
0.23%
Previous 0.39%
Shares
2 transactions
Others Institutions Holding ACRS
# of Institutions
112Shares Held
92.9MCall Options Held
35.4KPut Options Held
32K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$20.5 Million17.65% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$13.9 Million0.03% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$12.8 Million3.69% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD5.05MShares$7.27 Million0.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.97MShares$7.16 Million0.0% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $96M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...